MX2020009877A - Péptidos neutralizantes de miotoxina. - Google Patents

Péptidos neutralizantes de miotoxina.

Info

Publication number
MX2020009877A
MX2020009877A MX2020009877A MX2020009877A MX2020009877A MX 2020009877 A MX2020009877 A MX 2020009877A MX 2020009877 A MX2020009877 A MX 2020009877A MX 2020009877 A MX2020009877 A MX 2020009877A MX 2020009877 A MX2020009877 A MX 2020009877A
Authority
MX
Mexico
Prior art keywords
myotoxin
neutralizing
neutralizing peptides
envenomation
polypeptide
Prior art date
Application number
MX2020009877A
Other languages
English (en)
Inventor
Brian Lohse
Andreas Hougaard Laustsen
Ulate Julián Fernández
Saioa Oscoz Cob
Vigliotti Bruno Lomonte
GUTIÉRREZ José Maria GUTIÉRREZ
Original Assignee
Brian Lohse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brian Lohse filed Critical Brian Lohse
Publication of MX2020009877A publication Critical patent/MX2020009877A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a polipéptidos que tienen propiedades neutralizadoras de miotoxina y a su uso para el tratamiento de envenenamiento. La presente invención también se refiere a métodos para neutralizar un veneno utilizando el polipéptido de la invención, así como a métodos de tratamiento de envenenamiento administrando dicho polipéptido a un individuo que lo necesite.
MX2020009877A 2018-03-27 2019-03-26 Péptidos neutralizantes de miotoxina. MX2020009877A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18164297 2018-03-27
PCT/EP2019/057522 WO2019185593A1 (en) 2018-03-27 2019-03-26 Myotoxin-neutralizing peptides

Publications (1)

Publication Number Publication Date
MX2020009877A true MX2020009877A (es) 2021-01-08

Family

ID=61827626

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009877A MX2020009877A (es) 2018-03-27 2019-03-26 Péptidos neutralizantes de miotoxina.

Country Status (4)

Country Link
US (1) US11352393B2 (es)
BR (1) BR112020019213A2 (es)
MX (1) MX2020009877A (es)
WO (1) WO2019185593A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9303612D0 (sv) 1993-11-02 1993-11-02 Kabi Pharmacia Ab New use

Also Published As

Publication number Publication date
US20210070804A1 (en) 2021-03-11
BR112020019213A2 (pt) 2021-01-05
WO2019185593A1 (en) 2019-10-03
US11352393B2 (en) 2022-06-07

Similar Documents

Publication Publication Date Title
PH12018502538A1 (en) Antibodies to alpha-synuclein and uses thereof
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
MX2018007288A (es) Anticuerpos neutralizantes para el virus de inmunodeficiencia humana.
AR106753A1 (es) Proteínas de unión a ctla4p
MY187262A (en) Anti-lag3 antibodies and antigen-binding fragments
EA201990071A1 (ru) Композиция пептидной вакцины
EA201990298A1 (ru) Способы и композиции для лечения рака
UA117096C2 (uk) Поліпептид, що зв'язується з c5 комплементу людини
MX2021008207A (es) Proteínas de fusión multifuncionales y usos de las mismas.
PH12017500032A1 (en) Improved a� protofibril binding antibodies
MX2019003970A (es) Péptidos de arginasa inmunogénicos.
MX2019013801A (es) Compuestos de citocina inhibidora de macrofagos-1 (mic-1) y usos de estos.
MX2019006495A (es) Tratamiento de enfermedades neurologicas.
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
IN2014DN03213A (es)
MX2021003109A (es) Proteina para el tratamiento de enfermedades inflamatorias.
MY193807A (en) T-cell receptor and uses thereof
PH12017500156A1 (en) Angiopoietin-like 4 antibodies and methods of use
PH12020552222A1 (en) Immunodominant proteins and fragments in multiple sclerosis
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
PH12021550122A1 (en) Solubilized apyrases, methods and use
MY194448A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
EA202192460A1 (ru) Синтетические нейромодуляторные пептиды
NZ729514A (en) Therapeutic multi-peptides t specific immune therapy for treatment of brain metastasis
EA202191758A1 (ru) Пептиды для лечения и профилактики диабета и связанных с ним заболеваний